Eribulin-based antibody-drug conjugates and methods of use
US-2023398228-A1 · Dec 14, 2023 · US
This page is not indexed by search engines while we improve data quality.
Uenaka Toshimitsu patents
Uenaka Toshimitsu is listed as an inventor on 6 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Uenaka Toshimitsu |
| Total patents | 6 |
| First publication | Mar 16, 2017 |
| Latest publication | Dec 14, 2023 |
Notable patents
Publications ranked by popularity score, then publication date.
Eribulin-based antibody-drug conjugates and methods of use
US-2020297860-A1 · Sep 24, 2020 · US
Eribulin-based antibody-drug conjugates and methods of use
US-10548986-B2 · Feb 4, 2020 · US
Eribulin-based antibody-drug conjugates and methods of use
US-10322192-B2 · Jun 18, 2019 · US
Eribulin-based antibody-drug conjugates and methods of use
US-2018193478-A1 · Jul 12, 2018 · US
Use of eribulin and mtor inhibitors as combination therapy for the treatment of cancer
US-2017071903-A1 · Mar 16, 2017 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Eisai R&D Man Co Ltd | 6 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 6 |
| A61K31/357 | 6 |
| C07K2317/92 | 5 |
| A61K47/6889 | 5 |
| C07K2317/77 | 5 |